Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage

✍ Scribed by Chun-Jen Liu; Po-Huang Lee; Deng-Yn Lin; Cheng-Chung Wu; Long-Bin Jeng; Pin-Wen Lin; King-Tong Mok; Wei-Chen Lee; Hong-Zen Yeh; Ming-Chih Ho; Sheng-Shun Yang; Ching-Chih Lee; Ming-Chin Yu; Rey-Heng Hu; Cheng-Yuan Peng; Kuan-Lang Lai; Stanley Shi-Chung Chang; Pei-Jer Chen

• Book ID: 116651823
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 230 KB
• Volume: 50
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/j.jhep.2008.12.023